Co-Diagnostics (CODX) Lower on Reports of SEC Inquiries

June 17, 2021 9:49 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Co-Diagnostics (NASDAQ: CODX) ticks lower on reports from The Salt Lake Tribute that the SEC began making inquiries into its COVID-19 test. Shares are down 5%. (LINK)

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Litigation, Trader Talk